Clinical Specialties & Centres

Nuclear Medicine & PET Overview

Our centre is one of the region's largest Nuclear Medicine departments and provides a comprehensive range of clinical services in radioisotope imaging and therapy. We are equipped with a Positron Emission Tomography (PET)/CT scanner with Time-of-Flight technology, two Single Photon Emission Computed Tomography (SPECT)/CT scanners and three gamma cameras. We also have seven inpatient beds and three outpatient clinic rooms for therapy consultations.

Selective internal radiation therapy (SIRT)

Selective internal radiation therapy (SIRT) is a form of local radiation therapy for unresectable liver tumours. The procedure is performed in close coordination with interventional radiologists by delivering radioactive Yttrium-90 microspheres into the arteries supplying the tumours.

Peptide receptor radionuclide therapy (PRRT)

Peptide receptor radionuclide therapy (PRRT) is a molecular targeted therapy for inoperable metastatic well- or moderately-differentiated neuroendocrine tumours. It can also be used for other tumours with high somatostatin receptors expression. The treatment is performed with intravenous administration of radioactive somatostatin analogue (e.g. Lutetium-177 or Yttrium-90-labeled radiopeptide).

Iodine-131 MIBG therapy

Iodine-131 MIBG therapy is a systemically administered radiotherapy used in the treatment of inoperable metastatic neuroectodermal tumours such as pheochromocytoma, paraganglioma, neuroblastoma, medullary thyroid cancer and carcinoid tumors.

Radiosynovectomy

Radiosynovectomy is a radionuclide therapy to treat chronic joint synovitis or synovial processes. The majority of our referrals are of chronic inflammatory arthritis e.g. rheumatoid arthritis, and haemophilic synovitis. The treatment is performed by intra-articular injection of the colloidal form of Yttrium-90, Rhenium-186 and Erbium-169.

Bone pain palliative therapy

Bone-seeking radiopharmaceuticals (e.g. Strontium-89 chloride, Samarium-153, Rhenium-188) are used for the palliation of pain from bone metastases.